PPD

PPD names VP for global product development

Monday, September 23, 2013 01:30 PM

CRO PPD has appointed Gregory Dennis, M.D., vice president of global product development. Dennis will be therapeutic area head, providing medical and scientific expertise for rheumatology, immunology and inflammatory diseases.

More... »

PPD acquires Acurian

Tuesday, August 27, 2013 10:20 AM

Wilmington, N.C.-based CRO Pharmaceutical Product Development (PPD) has acquired Acurian, a provider of clinical trial patient enrollment and retention solutions for the life sciences industry. 

More... »

PPD names David Johnston executive vice president

Tuesday, August 13, 2013 11:30 AM

CRO Pharmaceutical Product Development (PPD) has appointed David Johnston, Ph.D., executive vice president of global laboratory services. Johnston directs PPD’s comprehensive laboratory services, including bioanalytical, vaccines and biologics, current good manufacturing practice (cGMP) and central laboratories.

More... »

SCRS launches Global Impact Partnership Program

Friday, June 21, 2013 10:35 AM

The Society for Clinical Research Sites (SCRS) has launched the Global Impact Partnership (GIP) Program. In just over one month, 12 organizations have joined as partners to provide ongoing development, feedback and support of industry initiatives designed to include and improve the voice of clinical research sites. 

More... »

PPD earns award for innovation in training and development

Monday, May 20, 2013 08:00 AM

Pharmaceutical Product Development (PPD), a global CRO, has been named by Skillsoft as a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning Cultures in the Enterprise.

More... »

BioDuro opens state-of-the-art discovery lab in Shanghai

Friday, May 17, 2013 10:59 AM

BioDuro, a drug discovery services company owned by PPD, has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific.

More... »

BioDelivery Sciences appoints Thomas W. D'Alonzo to board of directors

Tuesday, April 30, 2013 08:00 AM

BioDelivery Sciences International, a specialty pharmaceutical company, has appointed Thomas W. D'Alonzo to the company's board of directors.

More... »

PPD expands cGMP cell-based assay laboratory

Friday, March 29, 2013 02:14 PM

Pharmaceutical Product Development (PPD), a global CRO, is expanding itscGMP cell-based assay laboratory in Middleton, Wis., to meet the growing needs of clients seeking to validate bioassays for product release and stability testing of biological products, both as novel drugs and as biosimilars.

More... »

PPD appoints Jay Dixon as vice president, global quality and compliance

Tuesday, March 26, 2013 08:00 AM

Pharmaceutical Product Development (PPD), a global CRO, has appointed Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and high-quality data across the full spectrum of the research and development life cycle.

More... »

Ernest Mario named chairman of Chimerix

Wednesday, February 20, 2013 12:25 PM

Chimerix, a Durham, N.C.-based biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, has appointed Ernest Mario, Ph.D., as chairman of its board of directors.

More... »